Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1988 Jul;82(1):48–56. doi: 10.1172/JCI113600

Direct relationship between mononuclear leukocyte and lung beta-adrenergic receptors and apparent reciprocal regulation of extravascular, but not intravascular, alpha- and beta-adrenergic receptors by the sympathochromaffin system in humans.

S B Liggett 1, J C Marker 1, S D Shah 1, C L Roper 1, P E Cryer 1
PMCID: PMC303475  PMID: 2839552

Abstract

To examine putative relationships between adrenergic receptors on accessible circulating cells and relatively inaccessible extravascular catecholamine target tissues, we measured mononuclear leukocyte (MNL) and lung beta-adrenergic receptors and platelet and lung alpha-adrenergic receptors in tissues obtained from 15 patients undergoing pulmonary resection. Plasma catecholamine concentrations were measured concurrently to explore potential regulatory relationships between the activity of the sympathochromaffin system and both intravascular and extravascular adrenergic receptors. MNL and lung membrane beta-adrenergic receptor densities were correlated highly (r = 0.845, P less than 0.001). Platelet alpha 2-adrenergic receptor and lung alpha 1-adrenergic receptor densities were not. Lung alpha 1-adrenergic receptor densities were positively related to plasma norepinephrine (r = 0.840, P less than 0.01) and epinephrine (r = 0.860, P less than 0.01) concentrations; in contrast, lung beta-adrenergic receptor densities were not positively related to plasma catecholamine concentrations (they tended to be inversely related to plasma norepinephrine and epinephrine [r = -0.698, P less than 0.05] levels). This apparent reciprocal regulation of alpha- and beta-adrenergic receptors by the sympathochromaffin system was only demonstrable with adrenergic receptor measurements in the extravascular catecholamine target tissue. Neither MNL beta-adrenergic receptor nor platelet alpha-adrenergic receptor densities were correlated with plasma catecholamine levels. Thus, although measurements of beta-adrenergic receptors on circulating mononuclear leukocytes can be used as indices of extravascular target tissue beta-adrenergic receptor densities (at least in lung and heart), it would appear that extravascular tissues should be used to study adrenergic receptor regulation by endogenous catecholamines in humans. These data provide further support for the concept of up regulation, as well as down regulation, of some adrenergic receptor populations during short-term activation of the sympathochromaffin system in humans.

Full text

PDF
48

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aarons R. D., Molinoff P. B. Changes in the density of beta adrenergic receptors in rat lymphocytes, heart and lung after chronic treatment with propranolol. J Pharmacol Exp Ther. 1982 May;221(2):439–443. [PubMed] [Google Scholar]
  2. Bach M. A. Differences in Cyclic AMP Changes after Stimulation by Prostaglandins and Isoproterenol in Lymphocyte Subpopulations. J Clin Invest. 1975 May;55(5):1074–1081. doi: 10.1172/JCI108008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Barnes P. J., Basbaum C. B., Nadel J. A., Roberts J. M. Pulmonary alpha-adrenoceptors: autoradiographic localization using [3H]prazosin. Eur J Pharmacol. 1983 Mar 18;88(1):57–62. doi: 10.1016/0014-2999(83)90391-6. [DOI] [PubMed] [Google Scholar]
  4. Barnes P. J., Karliner J. S., Dollery C. T. Human lung adrenoreceptors studied by radioligand binding. Clin Sci (Lond) 1980 Jun;58(6):457–461. doi: 10.1042/cs0580457. [DOI] [PubMed] [Google Scholar]
  5. Barnes P., Karliner J., Hamilton C., Dollery C. Demonstration of alpha 1-adrenoceptors in guinea pig lung using 3H-prazosin. Life Sci. 1979 Oct 1;25(14):1207–1214. doi: 10.1016/0024-3205(79)90462-4. [DOI] [PubMed] [Google Scholar]
  6. Bilezikian J. P., Loeb J. N. The influence of hyperthyroidism and hypothyroidism on alpha- and beta-adrenergic receptor systems and adrenergic responsiveness. Endocr Rev. 1983 Fall;4(4):378–388. doi: 10.1210/edrv-4-4-378. [DOI] [PubMed] [Google Scholar]
  7. Bishopric N. H., Cohen H. J., Lefkowitz R. J. Beta adrenergic receptors in lymphocyte subpopulations. J Allergy Clin Immunol. 1980 Jan;65(1):29–33. doi: 10.1016/0091-6749(80)90173-6. [DOI] [PubMed] [Google Scholar]
  8. Brodde O. E., Bock K. D. Changes in platelet alpha 2-adrenoceptors in human phaeochromocytoma. Eur J Clin Pharmacol. 1984;26(2):265–267. doi: 10.1007/BF00630297. [DOI] [PubMed] [Google Scholar]
  9. Brodde O. E., Daul A., O'Hara N. Beta-adrenoceptor changes in human lymphocytes, induced by dynamic exercise. Naunyn Schmiedebergs Arch Pharmacol. 1984 Feb;325(2):190–192. doi: 10.1007/BF00506201. [DOI] [PubMed] [Google Scholar]
  10. Brodde O. E., Kretsch R., Ikezono K., Zerkowski H. R., Reidemeister J. C. Human beta-adrenoceptors: relation of myocardial and lymphocyte beta-adrenoceptor density. Science. 1986 Mar 28;231(4745):1584–1585. doi: 10.1126/science.3006250. [DOI] [PubMed] [Google Scholar]
  11. Burman K. D., Ferguson E. W., Djuh Y. Y., Wartofsky L., Latham K. Beta receptors in peripheral mononuclear cells increase acutely during exercise. Acta Endocrinol (Copenh) 1985 Aug;109(4):563–568. doi: 10.1530/acta.0.1090563. [DOI] [PubMed] [Google Scholar]
  12. Carstairs J. R., Nimmo A. J., Barnes P. J. Autoradiographic visualization of beta-adrenoceptor subtypes in human lung. Am Rev Respir Dis. 1985 Sep;132(3):541–547. doi: 10.1164/arrd.1985.132.3.541. [DOI] [PubMed] [Google Scholar]
  13. Chobanian A. V., Tifft C. P., Sackel H., Pitruzella A. Alpha and beta adrenergic receptor activity in circulating blood cells of patients with idiopathic orthostatic hypotension and pheochromocytoma. Clin Exp Hypertens A. 1982;4(4-5):793–806. doi: 10.3109/10641968209061613. [DOI] [PubMed] [Google Scholar]
  14. Cryer P. E. Physiology and pathophysiology of the human sympathoadrenal neuroendocrine system. N Engl J Med. 1980 Aug 21;303(8):436–444. doi: 10.1056/NEJM198008213030806. [DOI] [PubMed] [Google Scholar]
  15. Davis C., Conolly M. E., Greenacre J. K. Beta-adrenoceptors in human lung, bronchus and lymphocytes. Br J Clin Pharmacol. 1980 Nov;10(5):425–432. doi: 10.1111/j.1365-2125.1980.tb01783.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. De Lean A., Hancock A. A., Lefkowitz R. J. Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes. Mol Pharmacol. 1982 Jan;21(1):5–16. [PubMed] [Google Scholar]
  17. DeBlasi A., Maisel A. S., Feldman R. D., Ziegler M. G., Fratelli M., DiLallo M., Smith D. A., Lai C. Y., Motulsky H. J. In vivo regulation of beta-adrenergic receptors on human mononuclear leukocytes: assessment of receptor number, location, and function after posture change, exercise, and isoproterenol infusion. J Clin Endocrinol Metab. 1986 Oct;63(4):847–853. doi: 10.1210/jcem-63-4-847. [DOI] [PubMed] [Google Scholar]
  18. Doyle V. M., Bühler F. R., Bürgisser E. Inappropriate correction for radioactive decay in fully iodinated adrenergic radioligands. Eur J Pharmacol. 1984 Apr 6;99(4):353–356. doi: 10.1016/0014-2999(84)90146-8. [DOI] [PubMed] [Google Scholar]
  19. Elliott J. M., Peters J. R., Grahame-Smith D. G. Oestrogen and progesterone change the binding characteristics of alpha-adrenergic and serotonin receptors on rabbit platelets. Eur J Pharmacol. 1980 Aug 22;66(1):21–30. doi: 10.1016/0014-2999(80)90291-5. [DOI] [PubMed] [Google Scholar]
  20. Engel G. Subclasses of beta-adrenoceptors--a quantitative estimation of beta 1- and beta 2- adrenoceptors in guinea pig and human lung. Postgrad Med J. 1981;57 (Suppl 1):77–83. [PubMed] [Google Scholar]
  21. Ezrailson E. G., Garber A. J., Munson P. J., Swartz T. L., Birnbaumer L., Entman M. L. [125I]iodopindolol: a new beta adrenergic receptor probe. J Cyclic Nucleotide Res. 1981;7(1):13–26. [PubMed] [Google Scholar]
  22. Feldman R. D., Limbird L. E., Nadeau J., FitzGerald G. A., Robertson D., Wood A. J. Dynamic regulation of leukocyte beta adrenergic receptor-agonist interactions by physiological changes in circulating catecholamines. J Clin Invest. 1983 Jul;72(1):164–170. doi: 10.1172/JCI110954. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Feldman R. D., Limbird L. E., Nadeau J., Robertson D., Wood A. J. Leukocyte beta-receptor alterations in hypertensive subjects. J Clin Invest. 1984 Mar;73(3):648–653. doi: 10.1172/JCI111255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Fraser J., Nadeau J., Robertson D., Wood A. J. Regulation of human leukocyte beta receptors by endogenous catecholamines: relationship of leukocyte beta receptor density to the cardiac sensitivity to isoproterenol. J Clin Invest. 1981 Jun;67(6):1777–1784. doi: 10.1172/JCI110217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Ginsberg A. M., Clutter W. E., Shah S. D., Cryer P. E. Triiodothyronine-induced thyrotoxicosis increases mononuclear leukocyte beta-adrenergic receptor density in man. J Clin Invest. 1981 Jun;67(6):1785–1791. doi: 10.1172/JCI110218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Hasegawa M., Townley R. G. Alpha and beta adrenergic receptors of canine lung tissue identification and characterization of alpha adrenergic receptors by two different ligands. Life Sci. 1982 Mar 22;30(12):1035–1044. doi: 10.1016/0024-3205(82)90522-7. [DOI] [PubMed] [Google Scholar]
  27. Hedberg A., Kempf F., Jr, Josephson M. E., Molinoff P. B. Coexistence of beta-1 and beta-2 adrenergic receptors in the human heart: effects of treatment with receptor antagonists or calcium entry blockers. J Pharmacol Exp Ther. 1985 Sep;234(3):561–568. [PubMed] [Google Scholar]
  28. Hollister A. S., FitzGerald G. A., Nadeau J. H., Robertson D. Acute reduction in human platelet alpha 2-adrenoreceptor affinity for agonist by endogenous and exogenous catecholamines. J Clin Invest. 1983 Oct;72(4):1498–1505. doi: 10.1172/JCI111106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Khan M. M., Sansoni P., Silverman E. D., Engleman E. G., Melmon K. L. Beta-adrenergic receptors on human suppressor, helper, and cytolytic lymphocytes. Biochem Pharmacol. 1986 Apr 1;35(7):1137–1142. doi: 10.1016/0006-2952(86)90150-4. [DOI] [PubMed] [Google Scholar]
  30. Lachin J. M. Introduction to sample size determination and power analysis for clinical trials. Control Clin Trials. 1981 Jun;2(2):93–113. doi: 10.1016/0197-2456(81)90001-5. [DOI] [PubMed] [Google Scholar]
  31. Lefkowitz R. J., Caron M. G. Adrenergic receptors: molecular mechanisms of clinically relevant regulation. Clin Res. 1985 Sep;33(3):395–406. [PubMed] [Google Scholar]
  32. Mahan L. C., Insel P. A. Use of superoxide dismutase and catalase to protect catecholamines from oxidation in tissue culture studies. Anal Biochem. 1984 Jan;136(1):208–216. doi: 10.1016/0003-2697(84)90327-0. [DOI] [PubMed] [Google Scholar]
  33. Maisel A. S., Motulsky H. J., Insel P. A. Externalization of beta-adrenergic receptors promoted by myocardial ischemia. Science. 1985 Oct 11;230(4722):183–186. doi: 10.1126/science.2994229. [DOI] [PubMed] [Google Scholar]
  34. Malbon C. C., Greenberg M. L. 3,3',5-triiodothyronine administration in vivo modulates the hormone-sensitive adenylate cyclase system of rat hepatocytes. J Clin Invest. 1982 Feb;69(2):414–426. doi: 10.1172/JCI110465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Meier K. E., Sperling D. M., Insel P. A. Agonist-mediated regulation of alpha 1- and beta 2-adrenergic receptors in cloned MDCK cells. Am J Physiol. 1985 Jul;249(1 Pt 1):C69–C77. doi: 10.1152/ajpcell.1985.249.1.C69. [DOI] [PubMed] [Google Scholar]
  36. Mendelsohn J., Nordberg J. Adenylate cyclase in thymus-derived and bone marrow-derived lymphocytes from normal donors and patients with chronic lymphocytic leukemia. J Clin Invest. 1979 Jun;63(6):1124–1132. doi: 10.1172/JCI109405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Motulsky H. J., Cunningham E. M., DeBlasi A., Insel P. A. Desensitization and redistribution of beta-adrenergic receptors on human mononuclear leukocytes. Am J Physiol. 1986 May;250(5 Pt 1):E583–E590. doi: 10.1152/ajpendo.1986.250.5.E583. [DOI] [PubMed] [Google Scholar]
  38. Paietta E., Hoyer D., Engel G., Schwarzmeier J. D. Non-specific uptake of the radioligand 125I-IHYP by intact human lymphocytes: reversal of the uptake process. Mol Cell Endocrinol. 1982 Mar;25(3):267–276. doi: 10.1016/0303-7207(82)90083-1. [DOI] [PubMed] [Google Scholar]
  39. Pfeifer M. A., Ward K., Malpass T., Stratton J., Halter J., Evans M., Beiter H., Harker L. A., Porte D., Jr Variations in circulating catecholamines fail to alter human platelet alpha-2-adrenergic receptor number or affinity for [3H]yohimbine or [3H]dihydroergocryptine. J Clin Invest. 1984 Sep;74(3):1063–1072. doi: 10.1172/JCI111473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Ratge D., Wisser H. Alpha- and beta-adrenergic receptor activity in circulating blood cells of patients with phaeochromocytoma: effects of adrenalectomy. Acta Endocrinol (Copenh) 1986 Jan;111(1):80–88. doi: 10.1530/acta.0.1110080. [DOI] [PubMed] [Google Scholar]
  41. Roberts J. M., Goldfien R. D., Tsuchiya A. M., Goldfien A., Insel P. A. Estrogen treatment decreases alpha-adrenergic binding sites on rabbit platelets. Endocrinology. 1979 Mar;104(3):722–728. doi: 10.1210/endo-104-3-722. [DOI] [PubMed] [Google Scholar]
  42. Rosen S. G., Berk M. A., Popp D. A., Serusclat P., Smith E. B., Shah S. D., Ginsberg A. M., Clutter W. E., Cryer P. E. beta 2- and alpha 2-adrenergic receptors and receptor coupling to adenylate cyclase in human mononuclear leukocytes and platelets in relation to physiological variations of sex steroids. J Clin Endocrinol Metab. 1984 Jun;58(6):1068–1076. doi: 10.1210/jcem-58-6-1068. [DOI] [PubMed] [Google Scholar]
  43. Shah S. D., Clutter W. E., Cryer P. E. External and internal standards in the single-isotope derivative (radioenzymatic) measurement of plasma norepinephrine and epinephrine. J Lab Clin Med. 1985 Dec;106(6):624–629. [PubMed] [Google Scholar]
  44. Shah S. D., Tse T. F., Clutter W. E., Cryer P. E. The human sympathochromaffin system. Am J Physiol. 1984 Sep;247(3 Pt 1):E380–E384. doi: 10.1152/ajpendo.1984.247.3.E380. [DOI] [PubMed] [Google Scholar]
  45. Sibley D. R., Lefkowitz R. J. Molecular mechanisms of receptor desensitization using the beta-adrenergic receptor-coupled adenylate cyclase system as a model. Nature. 1985 Sep 12;317(6033):124–129. doi: 10.1038/317124a0. [DOI] [PubMed] [Google Scholar]
  46. Smith P. K., Krohn R. I., Hermanson G. T., Mallia A. K., Gartner F. H., Provenzano M. D., Fujimoto E. K., Goeke N. M., Olson B. J., Klenk D. C. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985 Oct;150(1):76–85. doi: 10.1016/0003-2697(85)90442-7. [DOI] [PubMed] [Google Scholar]
  47. Snavely M. D., Mahan L. C., O'Connor D. T., Insel P. A. Selective down-regulation of adrenergic receptor subtypes in tissues from rats with pheochromocytoma. Endocrinology. 1983 Jul;113(1):354–361. doi: 10.1210/endo-113-1-354. [DOI] [PubMed] [Google Scholar]
  48. Snavely M. D., Motulsky H. J., O'Connor D. T., Ziegler M. G., Insel P. A. Adrenergic receptors in human and experimental pheochromocytoma. Clin Exp Hypertens A. 1982;4(4-5):829–848. doi: 10.3109/10641968209061616. [DOI] [PubMed] [Google Scholar]
  49. Snavely M. D., Ziegler M. G., Insel P. A. Subtype-selective down-regulation of rat renal cortical alpha- and beta-adrenergic receptors by catecholamines. Endocrinology. 1985 Nov;117(5):2182–2189. doi: 10.1210/endo-117-5-2182. [DOI] [PubMed] [Google Scholar]
  50. Sowers J. R., Connelly-Fittinghoff M., Tuck M. L., Krall J. F. Acute changes in noradrenaline levels do not alter lymphocyte beta-adrenergic receptor concentrations in man. Cardiovasc Res. 1983 Mar;17(3):184–188. doi: 10.1093/cvr/17.3.184. [DOI] [PubMed] [Google Scholar]
  51. Strasser R. H., Stiles G. L., Lefkowitz R. J. Translocation and uncoupling of the beta-adrenergic receptor in rat lung after catecholamine promoted desensitization in vivo. Endocrinology. 1984 Oct;115(4):1392–1400. doi: 10.1210/endo-115-4-1392. [DOI] [PubMed] [Google Scholar]
  52. Tohmeh J. F., Cryer P. E. Biphasic adrenergic modulation of beta-adrenergic receptors in man. Agonist-induced early increment and late decrement in beta-adrenergic receptor number. J Clin Invest. 1980 Apr;65(4):836–840. doi: 10.1172/JCI109735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Winter R. J., Dickinson K. E., Rudd R. M., Sever P. S. Tissue specific modulation of beta-adrenoceptor number in rats with chronic hypoxia with an attenuated response to down-regulation by salbutamol. Clin Sci (Lond) 1986 Feb;70(2):159–165. doi: 10.1042/cs0700159. [DOI] [PubMed] [Google Scholar]
  54. Woodcock E. A., Johnston C. I. Changes in tissue alpha- and beta-adrenergic receptors in renal hypertension in the rat. Hypertension. 1980 Mar-Apr;2(2):156–161. doi: 10.1161/01.hyp.2.2.156. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES